Congress Wealth Management LLC DE Has $312,000 Position in HCA Healthcare, Inc. (NYSE:HCA)

Congress Wealth Management LLC DE grew its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,039 shares of the company’s stock after acquiring an additional 34 shares during the quarter. Congress Wealth Management LLC DE’s holdings in HCA Healthcare were worth $312,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Royal London Asset Management Ltd. lifted its position in HCA Healthcare by 62.0% during the 4th quarter. Royal London Asset Management Ltd. now owns 1,500,786 shares of the company’s stock worth $450,461,000 after buying an additional 574,239 shares in the last quarter. Principal Financial Group Inc. grew its stake in HCA Healthcare by 120.1% in the fourth quarter. Principal Financial Group Inc. now owns 873,775 shares of the company’s stock valued at $262,264,000 after purchasing an additional 476,756 shares in the last quarter. Meritage Group LP bought a new stake in shares of HCA Healthcare during the 3rd quarter worth approximately $150,548,000. Raymond James Financial Inc. bought a new position in shares of HCA Healthcare in the fourth quarter valued at $74,121,000. Finally, Canoe Financial LP lifted its stake in HCA Healthcare by 226,952.9% in the fourth quarter. Canoe Financial LP now owns 231,594 shares of the company’s stock valued at $69,513,000 after acquiring an additional 231,492 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

HCA stock opened at $342.25 on Friday. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The firm has a market cap of $84.26 billion, a P/E ratio of 15.58, a P/E/G ratio of 1.10 and a beta of 1.68. The company’s 50-day moving average price is $324.53 and its two-hundred day moving average price is $341.25. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period last year, the business posted $5.90 EPS. On average, analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be given a $0.72 dividend. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a yield of 0.84%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.11%.

Insider Activity

In other news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 1.30% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several brokerages recently issued reports on HCA. KeyCorp cut their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research note on Tuesday, January 7th. JPMorgan Chase & Co. reissued a “neutral” rating and set a $380.00 target price on shares of HCA Healthcare in a report on Tuesday, December 17th. Bank of America decreased their price objective on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $405.00 target price on shares of HCA Healthcare in a report on Monday, January 27th. Finally, Truist Financial cut their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $385.67.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.